List of Tables
Table 1. Thalassemia Market Trends
Table 2. Thalassemia Market Drivers & Opportunity
Table 3. Thalassemia Market Challenges
Table 4. Thalassemia Market Restraints
Table 5. Global Thalassemia Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Thalassemia Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Thalassemia Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Thalassemia Product Type
Table 9. Key Companies Time to Begin Mass Production of Thalassemia
Table 10. Global Thalassemia Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Thalassemia Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Thalassemia Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Thalassemia Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Thalassemia Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Thalassemia Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Thalassemia Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Thalassemia Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Thalassemia Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Thalassemia Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Thalassemia Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Thalassemia Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Thalassemia Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Thalassemia Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Thalassemia Sales Value by Region (2019-2024) & (%)
Table 27. Global Thalassemia Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Thalassemia Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Thalassemia Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Thalassemia Sales Value, (2025-2030) & (US$ Million)
Table 31. Bluebird bio, Inc. Basic Information List
Table 32. Bluebird bio, Inc. Description and Business Overview
Table 33. Bluebird bio, Inc. Thalassemia Products, Services and Solutions
Table 34. Revenue (US$ Million) in Thalassemia Business of Bluebird bio, Inc. (2019-2024)
Table 35. Bluebird bio, Inc. Recent Developments
Table 36. Acceleron Pharma, Inc. Basic Information List
Table 37. Acceleron Pharma, Inc. Description and Business Overview
Table 38. Acceleron Pharma, Inc. Thalassemia Products, Services and Solutions
Table 39. Revenue (US$ Million) in Thalassemia Business of Acceleron Pharma, Inc. (2019-2024)
Table 40. Acceleron Pharma, Inc. Recent Developments
Table 41. Celgene Corporation Basic Information List
Table 42. Celgene Corporation Description and Business Overview
Table 43. Celgene Corporation Thalassemia Products, Services and Solutions
Table 44. Revenue (US$ Million) in Thalassemia Business of Celgene Corporation (2019-2024)
Table 45. Celgene Corporation Recent Developments
Table 46. GlaxoSmithKline plc Basic Information List
Table 47. GlaxoSmithKline plc Description and Business Overview
Table 48. GlaxoSmithKline plc Thalassemia Products, Services and Solutions
Table 49. Revenue (US$ Million) in Thalassemia Business of GlaxoSmithKline plc (2019-2024)
Table 50. GlaxoSmithKline plc Recent Developments
Table 51. Incyte Corporation Basic Information List
Table 52. Incyte Corporation Description and Business Overview
Table 53. Incyte Corporation Thalassemia Products, Services and Solutions
Table 54. Revenue (US$ Million) in Thalassemia Business of Incyte Corporation (2019-2024)
Table 55. Incyte Corporation Recent Developments
Table 56. Gamida Cell Basic Information List
Table 57. Gamida Cell Description and Business Overview
Table 58. Gamida Cell Thalassemia Products, Services and Solutions
Table 59. Revenue (US$ Million) in Thalassemia Business of Gamida Cell (2019-2024)
Table 60. Gamida Cell Recent Developments
Table 61. Kiadis Pharma Basic Information List
Table 62. Kiadis Pharma Description and Business Overview
Table 63. Kiadis Pharma Thalassemia Products, Services and Solutions
Table 64. Revenue (US$ Million) in Thalassemia Business of Kiadis Pharma (2019-2024)
Table 65. Kiadis Pharma Recent Developments
Table 66. La Jolla Pharmaceutical Company Basic Information List
Table 67. La Jolla Pharmaceutical Company Description and Business Overview
Table 68. La Jolla Pharmaceutical Company Thalassemia Products, Services and Solutions
Table 69. Revenue (US$ Million) in Thalassemia Business of La Jolla Pharmaceutical Company (2019-2024)
Table 70. La Jolla Pharmaceutical Company Recent Developments
Table 71. IONIS Pharmaceuticals Basic Information List
Table 72. IONIS Pharmaceuticals Description and Business Overview
Table 73. IONIS Pharmaceuticals Thalassemia Products, Services and Solutions
Table 74. Revenue (US$ Million) in Thalassemia Business of IONIS Pharmaceuticals (2019-2024)
Table 75. IONIS Pharmaceuticals Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Thalassemia Downstream Customers
Table 79. Thalassemia Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Thalassemia Product Picture
Figure 2. Global Thalassemia Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Thalassemia Sales Value (2019-2030) & (US$ Million)
Figure 4. Thalassemia Report Years Considered
Figure 5. Global Thalassemia Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Thalassemia Revenue in 2023
Figure 7. Thalassemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Iron Chelating Drugs Picture
Figure 9. Others Picture
Figure 10. Global Thalassemia Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Thalassemia Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Product Picture of Research Institute
Figure 15. Product Picture of Laboratories
Figure 16. Product Picture of Others
Figure 17. Global Thalassemia Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Thalassemia Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Thalassemia Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Thalassemia Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Thalassemia Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Thalassemia Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Thalassemia Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Thalassemia Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Thalassemia Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Thalassemia Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Thalassemia Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Thalassemia Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Thalassemia Sales Value (%), (2019-2030)
Figure 30. United States Thalassemia Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Thalassemia Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Thalassemia Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Thalassemia Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Thalassemia Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Thalassemia Sales Value by Application (%), 2023 VS 2030
Figure 36. China Thalassemia Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Thalassemia Sales Value by Type (%), 2023 VS 2030
Figure 38. China Thalassemia Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Thalassemia Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Thalassemia Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Thalassemia Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Thalassemia Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Thalassemia Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Thalassemia Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Thalassemia Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Thalassemia Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Thalassemia Sales Value by Application (%), 2023 VS 2030
Figure 48. India Thalassemia Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Thalassemia Sales Value by Type (%), 2023 VS 2030
Figure 50. India Thalassemia Sales Value by Application (%), 2023 VS 2030
Figure 51. Thalassemia Industrial Chain
Figure 52. Thalassemia Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation